|
FDA requests another major year-over-year budget increase
Less than a week after president Obama proposed a spending freeze on non-security related federal programs, the FDA released its fiscal year 2011 budget request, calling for a 23% increase. More...
AstraZeneca announces jobs cuts and R&D restructuring
AstraZeneca plans to undertake further restructuring in its R&D operations, resulting in the elimination of 3500 jobs. More...
Pfizer streamlines and prioritizes pipeline
Pfizer’s first updated pipeline since its acquisition of Wyeth includes fewer projects than before and is targeted to specific diseases; after the acquisition, the companies’ combined pipeline had 600 projects, but the number has been reduced to about 500. More...
Capsules release drug by rubbing skin
Capsules that can release their contents at a selected temperature have been developed by researchers in France, and could lead to the development of therapeutic agents that are applied to the skin and triggered locally by rubbing. More...
Product planning groups integral to drive profitability
A highly functioning New Product Planning (NPP) group is a company’s first line of defence against losses caused by products that fail to reach the market, according to research and consulting firm Best Practices LLC. More...
Join PTE on LinkedIn!
Join Pharmaceutical Technology Europe's group on LinkedIn. More...
Event Profile |
Pharma Congress |
9-10 March 2010 Dusseldorf, Germany
The Pharma Congress Production & Technology has been Germany's leading convention in the pharma environment for 11 years, combining high-class special subject matter conferences, an adjacent exhibition and directly connected hotel accommodation.
Read more... |
|
|
|
|
LogiPharma 2010 |
27-29 April
Intercontinental Hotel, Geneva
Today, more than ever before, supply chain managers must focus on cost-cutting, outsourcing logistics, improving customer service along the supply chain, improving supply chain agility, safety and visibility, all while remaining compliant with changing regulations.
Read more...
Podcast |
Vetter Development Service Chicago |
Peter Soelkner
Managing Director, Vetter Pharma International GmbH
Listen to this podcast recorded live from the show floor of AAPS 2009. Clinical development is key for new drugs. In order to minimize risks and take advantage of opportunities, you need comprehensive know-how and years of experience. Vetter, as a specialist in the aseptic filling of injection systems, will provide with its new facility the manufacturing of preclinical, Phase I and Phase II clinical batches in Chicago. We invite you to find out more about Vetter Development Services USA Inc.
Read more... |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|